Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVT-1 in Advanced Refractory NSCLC
NCT04840004Phase 2Recruiting
- Sponsor
- PlusVitech
- Start
- Mar 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in non-small cell lung cancer (NSCLC), sponsored by PlusVitech. Started Mar 2021; status: recruiting.
02
Drugs
aprepitant
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04840004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840004.